N/A
Completed N=47
Novel Application of Simulation for Providers to Overcome Decisional Gaps in High-risk Prescribing
Medication Administered in Error · Antipsychotics and Neuroleptics Toxicity
Source: ClinicalTrials.gov NCT04668248 ↗
Enrolled (actual)
47
Serious AEs
0.0%
Results posted
Feb 2023
Primary outcomePrimary: High-risk Medication Doses — 0.049; 0.052; 0.036; 0.019 No. of med orders by patient per intern
Summary
This pilot project aims to reduce the prescribing of high-risk medications, such as antipsychotics and benzodiazepines, to hospitalized older adults. To accomplish this, this project consists of two phases. The purpose is to determine whether a novel simulation-based training program reduces prescribing of suboptimal medications for older adults. A 2-arm pilot randomized controlled trial will be conducted to test a simulation-based, principle-driven intervention targeting high-risk prescribing practices versus control.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY High-risk Medication Doses |
0.049; 0.052; 0.036; 0.019; 0.013; 0.032 | — |
| SECONDARY Percentage of Patients Discharged With Inappropriate Medications |
27.0; 20.0 | — |
Eligibility Criteria
Residents and interns at Brigham and Women's Hospital will be eligible for this trial if they care for older adults (age 65+) admitted to one of the general medicine wards during an evening shift.
Data sourced from ClinicalTrials.gov (NCT04668248). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.